roxatidine acetate has been researched along with bismuth tripotassium dicitrate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azian, M; Chuah, SY; Goh, KL; Lo, YL; Ong, KK; Parasakthi, N; Peh, SC; Wong, NW | 1 |
| Ivanov, CH; Klouchek, E; Krushkov, I; Marazova, K; Popov, A | 1 |
1 trial(s) available for roxatidine acetate and bismuth tripotassium dicitrate
| Article | Year |
|---|---|
Roxithromycin in the eradication of Helicobacter pylori.
Topics: Anti-Ulcer Agents; Bismuth; Drug Therapy, Combination; Helicobacter Infections; Helicobacter pylori; Histamine H2 Antagonists; Humans; Omeprazole; Organometallic Compounds; Piperidines; Roxithromycin | 1994 |
1 other study(ies) available for roxatidine acetate and bismuth tripotassium dicitrate
| Article | Year |
|---|---|
Gastroprotective effect of MX1 (a novel salt of the active metabolite of roxatidine with a complex of bismuth and citric acid) against stress ulcers in rats.
Topics: Animals; Antacids; Anti-Ulcer Agents; Drug Combinations; Gastric Mucosa; Histamine H2 Antagonists; Male; Organometallic Compounds; Peptic Ulcer; Piperidines; Rats; Rats, Wistar; Restraint, Physical | 1997 |